ストックスクリーナーアプリを入手
15.84
1.49%
-0.24
前日終値:
$16.08
開ける：
$16.22
24時間の取引高:
2.00M
Relative Volume:
0.87
時価総額：
$3.74B
収益：
$382.81M
当期純損益:
$68.13M
株価収益率:
56.57
EPS:
0.28
ネットキャッシュフロー:
$78.82M
1週間 パフォーマンス:
-0.38%
1か月 パフォーマンス:
-1.98%
6か月 パフォーマンス:
-11.21%
1年 パフォーマンス:
+205.79%
1日の値動き範囲:
$15.73
$16.40
1週間の範囲:
$15.60
$16.67
52週間の値動き範囲:
$5.08
$23.64
Adma Biologics Inc Stock (ADMA) Company Profile
ADMA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
15.84 | 3.74B | 382.81M | 68.13M | 78.82M | 0.28 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-19 | 再開されました | Raymond James | Strong Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2021-11-11 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 開始されました | Jefferies | Buy |
| 2019-04-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-07 | 再開されました | H.C. Wainwright | Buy |
| 2017-12-11 | 繰り返されました | Maxim Group | Buy |
| 2017-11-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | アップグレード | Maxim Group | Hold → Buy |
| 2016-08-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2016-07-25 | 繰り返されました | Maxim Group | Buy |
| 2015-05-13 | 繰り返されました | Maxim Group | Buy |
| 2014-12-08 | 開始されました | Oppenheimer | Outperform |
| 2014-12-01 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Adma Biologics Inc (ADMA) 最新ニュース
ADMA Biologics announces executive and director compensation changes By Investing.com - Investing.com Nigeria
ADMA Biologics announces executive and director compensation changes - Investing.com
Adma Biologics (ADMA) Stock Moves -1.49%: What You Should Know - Yahoo Finance
(ADMA) Technical Pivots with Risk Controls - Stock Traders Daily
Adma Biologics (ADMA) Rises Higher Than Market: Key Facts - MSN
ADMA Biologics Gears Up to Report Q4 Earnings: What's in the Cards? - MSN
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade - Nasdaq
Allspring Global Investments Holdings LLC Buys 2,613,482 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Legato Capital Management LLC Reduces Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
SG Americas Securities LLC Cuts Position in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Nkcfo LLC Makes New Investment in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Empowered Funds LLC Invests $5.68 Million in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
Adma Biologics (ADMA) Stock Moves -0.25%: What You Should Know - Nasdaq
Pharma Stock Poised to Bounce Off Support - Yahoo Finance
When the Price of (ADMA) Talks, People Listen - Stock Traders Daily
ADMA Loses 8.9% in a Month: How Should You Play the Stock? - MSN
Adma Biologics (ADMA) Advances But Underperforms Market: Key Facts - MSN
ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Holdings Lifted by Calamos Advisors LLC - MarketBeat
ADMA Biologics: Recent Pullback Is A Perfect Opportunity To Add (NASDAQ:ADMA) - Seeking Alpha
Exploring Three High Growth Tech Stocks in the United States - Simply Wall St
Janney Montgomery Scott LLC Sells 6,603 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Pacer Advisors Inc. Sells 866 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - ETF Daily News
Engaging In Insider Activity, Kaitlin M. Kestenberg-Messina At ADMA Biologics Exercises Options Worth $28K - Benzinga
Will Weakness in ADMA Biologics, Inc.'s (NASDAQ:ADMA) Stock Prove Temporary Given Strong Fundamentals? - Simply Wall St
Pacer Advisors Inc. Has $656,000 Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note - Nasdaq
Short Interest in ADMA Biologics, Inc. (NASDAQ:ADMA) Increases By 11.8% - MarketBeat
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Bought by Nisa Investment Advisors LLC - Defense World
Jim Cramer on ADMA Biologics, Inc. (ADMA): ‘I Would Wait For It To Come Down Before I Would Pull The Trigger’ - Insider Monkey
8 Stocks on Jim Cramer’s Radar - Insider Monkey
Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business' - Benzinga
Where are the Opportunities in (ADMA) - Stock Traders Daily
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance
ADMA STOCK DROP ALERT: ADMA Biologics, Inc. Stock Drops over 20%; BFA Law Initiates Securities Fraud Investigation and Urges Investors with Losses to Contact the Firm (Nasdaq:ADMA) - ACCESS Newswire
ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Inspire Investing LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ADMA Biologics Inc (ADMA) And Encourages Investors to Reach Out - ACCESS Newswire
Veracity Capital LLC Boosts Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Biologics to acquire certain assets from Biotest Pharmaceuticals Corp - Reuters
Peering Into ADMA Biologics's Recent Short Interest - Benzinga
Brokers Set Expectations for ADMA Biologics FY2025 Earnings - MarketBeat
Perpetual Ltd Acquires Shares of 3,632,677 ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat
ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock? - MSN
Blood Plasma Market Growing at 4.07% CAGR to Hit 42.0 Billion USD by 2032 | Emergent BioSolutions, ADMA - EIN News
There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat
Adma Biologics Inc (ADMA) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):